Fosun Pharmaceuticals

FIPB Clears Fosun – Gland Pharma Deal

Shanghai Fosun Pharmaceuticals (Group) Co. Ltd has received approval from Foreign Investment Promotion Board (FIPB) to pick up a majority stake in Hyderabad-based Gland...
Medherant

Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer

Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, has...
abbott

Abbott’s Stent Faces Another Storm, This Time On Safety

Even as healthcare major Abbott's bio-absorable stent ‘Absorb' battles price control challenges in India, another storm seems to be blowing in from Europe. The healthcare...
Domain Therapeutics

Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAll™

Strasbourg, France, and Montreal, Canada, April 25, 2017 - Domain Therapeutics, a France- and Quebec-based biopharmaceutical company specializing in the research and development of...
Indian pharmaceuticals

Indian Pharmaceuticals M&A Deals Touch $4.6 Billion In 2016

Indian pharmaceuticals sector witnessed 51 deals being announced in the year 2016, with aggregate disclosed deal value of $4.6 billion. Unlike the trend in...
Vygon Group

Enteral feeding: Vygon Group launches safe-enteral.com

Vygon is keen to raise awareness amongst medical staff about the benefits of new standardized enteral connectors and the potential risks when used in...
Pharmaceutical

California Presses Forward In Fight To Regulate Pharmaceutical Companies

In November, California voters defeated a ballot proposal that would have given state government more control over drug prices. It was a victory for pharmaceutical companies, which spent...
tuberculosis

Health Organisations Write to Narendra Modi, Seek Compulsory Licences For Tuberculosis Drugs

Six health organisations and survivors of drug-resistant tuberculosis, health organisations and the TB community have appealed to Prime Minister Narendra Modi to allow issuance...
Ocrevus

USFDA Approved Ocrevus To Treat Multiple Sclerosis

THERAPEUTIC ADVANCE The United States Food and Drug Administration has approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and...
ATUM

ATUM Launches Cell-Line Development Service

Newark, USA, 10th April 2017 / ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled...